Robatumumab (IGF1R/CD221) - Research Grade Biosimilar
Product Specifications
Background
Robatumumab has been used in trials studying the treatment of Osteosarcoma, Sarcoma, Ewing's, and Peripheral Neuroectodermal Tumor.
Immunogen
Homo sapiens / IGF1R/CD221 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Product Datasheet
https://www.prosci-inc.com/?datasheet_sku=10-312
Fragment
IgG1-kappa
NCBI Organism
Homo sapiens
Other Product Names
19D12, SCH 717454
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx314717-01 20 µg
Transforming Acidic Coiled-Coil-Containing Protein 3 (TACC3) Antibody (FITC)
Ask
View Details 
abx314717-02 50 µg
Transforming Acidic Coiled-Coil-Containing Protein 3 (TACC3) Antibody (FITC)
Ask
View Details 
abx314717-03 100 µg
Transforming Acidic Coiled-Coil-Containing Protein 3 (TACC3) Antibody (FITC)
Ask
View Details 
abx314717-04 200 µg
Transforming Acidic Coiled-Coil-Containing Protein 3 (TACC3) Antibody (FITC)
Ask
View Details abx314717-05 1 mg
Transforming Acidic Coiled-Coil-Containing Protein 3 (TACC3) Antibody (FITC)
Ask
View Details